1025 Results for: "TMC HALLCREST"

Supplier: Merck

N,O-Bis(trimethylsilyl)acetamide : chlorotrimethylsilane : 1-(trimethylsilyl)imidazole (BSA+TMCS+TMSI) silylating mixture II according to Horning, LiChropur™ for GC derivatisation, Supelco®

Supplier: Merck

Chlorotrimethylsilane for synthesis, Sigma-Aldrich®

Supplier: Merck

N,O-Bis(trimethylsilyl)trifluoroacetamide with 1% trimethylchlorosilane, Cerilliant® for GC derivatisation, analytical standard, Supelco®

Supplier: Merck

Suitable for the derivatization of a-ketoacids, amines, amino acids, cycloserine, histamine and metabolites, phenylethylamines, phosphatidylserines and tryptamines.

Supplier: Merck

N,O-Bis(trimethylsilyl)trifluoroacetamide with 10% trimethylchlorosilane 98% (excluding TMCS) (by GC), LiChropur™ for GC derivatisation, Supelco®

Supplier: Merck

N,O-Bis(trimethylsilyl)trifluoroacetamide with 1% trimethylchlorosilane 99% (excluding TMCS) (by GC), LiChropur™ for GC derivatisation, Supelco®

Supplier: Merck

N,O-Bis-(trimethylsilyl)-trifluoracetamide : chlorotrimethylsilane : 1-(trimethylsilyl)imidazole (BSTFA/TMCS/TMSI) mixture 3:3:2 (v/v/v) silylating mixture III, LiChropur™ for GC derivatisation, Supelco®

Supplier: Merck

N,O-Bis(trimethylsilyl)trifluoroacetamide with 1% trimethylchlorosilane, Supelco®

Supplier: Merck

Hexamethyldisilazane/chlorotrimethylsilane/pyridine = 2:1:10 (v/v/v), useful silylating mixture for the silylation of hydroxy-compounds.

Supplier: TCI

TMS-HT (=HMDS and TMCS in anhydrous pyridine) Trimethylsilylating Reagent, for OH compounds

Supplier: Thermo Fisher Scientific

N,O-Bis(trimethylsilyl)trifluoroacetamide with 1% trimethylchlorosilane

Supplier: Thermo Fisher Scientific

Chlorotrimethylsilane 98%

Supplier: Apollo Scientific

Polymer. Lactide:TMC 50:50. Viscosity 1.5 dL/g

Supplier: Merck

Chlorotrimethylsilane is a silylation reagent used in the derivatization of triglycerides into volatile fatty esters by gas chromatography (GC).

Supplier: JSP

The Thermex™ is an advanced double lensed goggle with TMC™ technology that offers fog-free use, even in extreme temperatures.

Supplier: TCI

Chlorotrimethylsilane ≥98.0% (by GC)

Supplier: Thermo Fisher Scientific

packaged under Argon in resealable ChemSeal™ bottles

Supplier: Apollo Scientific

Chlorotrimethylsilane 99%

Supplier: Thermo Fisher Scientific

Chlorotrimethylsilane ≥98%

Supplier: Merck

N-Methyl-N-(trimethylsilyl)trifluoroacetamide with 1% trimethylchlorosilane, LiChropur™ silylation reagent, for GC derivatisation, Supelco®

Supplier: TCI

TMS-HT (=HMDS and TMCS in anhydrous pyridine) for gas chromatography

Supplier: TCI

N,O-Bis(trimethylsilyl)trifluoroacetamide with 1% trimethylchlorosilane (99:1) for GC derivatisation

Supplier: Bioss

Transmembrane channel-like protein 8 (TMC8), also known as Epidermodysplasia verruciformis protein 2 (EVER2), is a 726 amino acid member of the TMC family of proteins. Localized to the endoplasmic reticulum membrane, TMC8 is thought to form a transmembrane channel-like protein with eight predicted transmembrane domains and three leucine zipper motifs. Mutations in the genes encoding TMC8 and TMC6, another member of the TMC family, have been shown to cause epidermodysplasia verruciformis (EV), an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. Infection by HPVs lead to persistent wart-like or macular lesions. TMC8 is expressed in placenta, prostate and testis, and three named isoforms exist as a result of alternative splicing events.

Supplier: Bioss

Transmembrane channel-like protein 8 (TMC8), also known as Epidermodysplasia verruciformis protein 2 (EVER2), is a 726 amino acid member of the TMC family of proteins. Localized to the endoplasmic reticulum membrane, TMC8 is thought to form a transmembrane channel-like protein with eight predicted transmembrane domains and three leucine zipper motifs. Mutations in the genes encoding TMC8 and TMC6, another member of the TMC family, have been shown to cause epidermodysplasia verruciformis (EV), an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. Infection by HPVs lead to persistent wart-like or macular lesions. TMC8 is expressed in placenta, prostate and testis, and three named isoforms exist as a result of alternative splicing events.

Supplier: Thermo Fisher Scientific

Chlorotrimethylsilane 98%, AcroSeal® for synthesis

Supplier: Bioss

Transmembrane channel-like protein 8 (TMC8), also known as Epidermodysplasia verruciformis protein 2 (EVER2), is a 726 amino acid member of the TMC family of proteins. Localized to the endoplasmic reticulum membrane, TMC8 is thought to form a transmembrane channel-like protein with eight predicted transmembrane domains and three leucine zipper motifs. Mutations in the genes encoding TMC8 and TMC6, another member of the TMC family, have been shown to cause epidermodysplasia verruciformis (EV), an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. Infection by HPVs lead to persistent wart-like or macular lesions. TMC8 is expressed in placenta, prostate and testis, and three named isoforms exist as a result of alternative splicing events.

Supplier: Bioss

Transmembrane channel-like protein 8 (TMC8), also known as Epidermodysplasia verruciformis protein 2 (EVER2), is a 726 amino acid member of the TMC family of proteins. Localized to the endoplasmic reticulum membrane, TMC8 is thought to form a transmembrane channel-like protein with eight predicted transmembrane domains and three leucine zipper motifs. Mutations in the genes encoding TMC8 and TMC6, another member of the TMC family, have been shown to cause epidermodysplasia verruciformis (EV), an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. Infection by HPVs lead to persistent wart-like or macular lesions. TMC8 is expressed in placenta, prostate and testis, and three named isoforms exist as a result of alternative splicing events.

Supplier: Bioss

Transmembrane channel-like protein 8 (TMC8), also known as Epidermodysplasia verruciformis protein 2 (EVER2), is a 726 amino acid member of the TMC family of proteins. Localized to the endoplasmic reticulum membrane, TMC8 is thought to form a transmembrane channel-like protein with eight predicted transmembrane domains and three leucine zipper motifs. Mutations in the genes encoding TMC8 and TMC6, another member of the TMC family, have been shown to cause epidermodysplasia verruciformis (EV), an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. Infection by HPVs lead to persistent wart-like or macular lesions. TMC8 is expressed in placenta, prostate and testis, and three named isoforms exist as a result of alternative splicing events.

Supplier: Bioss

Transmembrane channel-like protein 8 (TMC8), also known as Epidermodysplasia verruciformis protein 2 (EVER2), is a 726 amino acid member of the TMC family of proteins. Localized to the endoplasmic reticulum membrane, TMC8 is thought to form a transmembrane channel-like protein with eight predicted transmembrane domains and three leucine zipper motifs. Mutations in the genes encoding TMC8 and TMC6, another member of the TMC family, have been shown to cause epidermodysplasia verruciformis (EV), an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. Infection by HPVs lead to persistent wart-like or macular lesions. TMC8 is expressed in placenta, prostate and testis, and three named isoforms exist as a result of alternative splicing events.

Supplier: Bioss

Transmembrane channel-like protein 8 (TMC8), also known as Epidermodysplasia verruciformis protein 2 (EVER2), is a 726 amino acid member of the TMC family of proteins. Localized to the endoplasmic reticulum membrane, TMC8 is thought to form a transmembrane channel-like protein with eight predicted transmembrane domains and three leucine zipper motifs. Mutations in the genes encoding TMC8 and TMC6, another member of the TMC family, have been shown to cause epidermodysplasia verruciformis (EV), an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. Infection by HPVs lead to persistent wart-like or macular lesions. TMC8 is expressed in placenta, prostate and testis, and three named isoforms exist as a result of alternative splicing events.